Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zachary Rattner

Vascular & Interventional Radiology San Diego, CA Medical Doctor

NPI 1003867276 CMS profile 181771

995 Gateway Center Way, Suite 207, San Diego, CA 92102

Open in the dashboard

General payments

$58,884

117 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zachary Rattner of San Diego, CA is reported in the CMS Open Payments database as having received $58,884 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,258 17
2024 General $16,503 33
2023 General $15,163 8
2022 General $6,127 14
2021 General $185 9
2020 General $1,858 14
2019 General $3,790 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zachary Rattner
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Zachary Rattner were reported at $15,258. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Zachary Rattner Vascular & Interventional Radiology median Middle half National median
2019 $3,790 $422 $125–$1,555 $163
2020 $1,858 $200 $68–$652 $114
2021 $185 $280 $99–$866 $132
2022 $6,127 $433 $137–$1,497 $149
2023 $15,163 $506 $152–$2,019 $160
2024 $16,503 $556 $175–$1,930 $164
2025 $15,258 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $51,305 34 payments
  2. Medtronic Vascular, Inc. $4,874 11 payments
  3. Nevro Corp. $1,110 9 payments
  4. Cardinal Health 200, LLC $268 3 payments
  5. Covidien LP $209 5 payments
  6. Philips Electronics North America Corporation $206 11 payments
  7. Bard Peripheral Vascular, Inc. $143 6 payments
  8. Medtronic, Inc. $110 5 payments
  9. Boston Scientific Corporation $107 6 payments
  10. Cook Medical LLC $97 5 payments
  11. Other $455 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $50,875 4 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,600 3 payments
  3. Food and Beverage $2,445 107 payments
  4. Travel and Lodging $964 3 payments
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Et $35,875 3 payments
  2. Auryon Laser System 100-120 Vac Cv $15,000 1 payment
  3. VenaSeal $3,190 8 payments
  4. ClosureFast $1,850 6 payments
  5. Senza $1,110 9 payments
  6. AURYON LASER SYSTEM 100-120 VAC Pad $430 30 payments
  7. SABER $71 3 payments
  8. (6536) Phoenix $60 3 payments
  9. IGT D Peripheral $55 3 payments
  10. VARITHENA $54 3 payments
  11. Other $881 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

57

Median for Interventional Radiology: 38

Drug cost

$1,086

Median for Interventional Radiology: $333

Branded share of claims

38.6%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cilostazol Generic 35 $585
Clopidogrel Clopidogrel Bisulfate Brand 22 $502

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$175,701

Of which drugs: $739

Medicare patients

244

Average age 72

Services billed

3,029

141 women, 103 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 61%
Chronic kidney disease 52%
Arthritis 48%
Ischemic heart disease 39%
Heart failure 36%
Depression 24%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 22 2,300 $242

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record